SMDT1

Across TCGA pan-cancer cohorts, SMDT1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SMDT1’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where SMDT1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SMDT1 is over-expressed in tumor, although a few such as LSCC and CCRCC show the opposite, repressed pattern.

LUAD, LSCC, and CCRCC are the cancer types where SMDT1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SMDT1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	+0.382	<.001	7	view →
LSCC	Male	II,III,IV	−0.286	<.001	4	view →
CCRCC	Female	III,IV	−0.281	.016	3	view →
PDAC	All	II,III,IV	+0.540	.014	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

SMDT1–LUAD

Open the LUAD breakdown →